Core Laboratories (CLB) Change in Account Payables (2022 - 2026)

Core Laboratories' Change in Account Payables history runs 5 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• On a quarterly basis, Change in Account Payables fell 4.17% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $353000.0, a 91.26% decrease from a year earlier, with the FY2025 full-year figure at $477000.0, down 8.09% from the prior year.
• Change in Account Payables grew to $2.8 million in Q1 2026 per CLB's latest filing, from -$807000.0 in the prior quarter.
• Across five years, Change in Account Payables topped out at $11.1 million in Q4 2022 and bottomed at -$7.1 million in Q1 2023.
• The 5-year median for Change in Account Payables is -$551000.0 (2024), against an average of $85133.3.
• Across the five-year window, Change in Account Payables plunged 470.54% in 2023 and surged 639.2% in 2025, its largest moves.
• Year by year, Change in Account Payables stood at $11.1 million in 2022, then tumbled by 97.99% to $223000.0 in 2023, then surged by 300.0% to $892000.0 in 2024, then tumbled by 190.47% to -$807000.0 in 2025, then surged by 452.79% to $2.8 million in 2026.
• Per Business Quant, the three latest CLB Change in Account Payables figures stand at $2.8 million (Q1 2026), -$807000.0 (Q4 2025), and -$5.4 million (Q3 2025).